# Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia

> **NCT00087555** · PHASE2 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 195 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Xyrem (sodium oxybate) oral solution
- **DRUG:** Xyrem (sodium oxybate) oral solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00087555
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-04
- **Final completion:** 2006-01
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2012-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00087555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00087555, "Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00087555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*